Terrence W. Norchi

CEO of Arch Therapeutics, Inc. at Arch Therapeutics, Inc.
Terrence W. Norchi, MD is president and CEO of Framingham, MA-based Arch Therapeutics, Inc. Arch's flagship development stage product candidate, the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.
Want to write for Entrepreneur too? Apply to join Entrepreneur Leadership network.

More From Terrence W. Norchi

More Authors You Might Like